Works matching IS 08876924 AND DT 2011 AND VI 25 AND IP 2

Results: 31

IDH1 and IDH2 mutations are rare in pediatric myeloid malignancies.

Published in:

2011

By:

Oki, K.;
Takita, J.;
Hiwatari, M.;
Nishimura, R.;
Sanada, M.;
Okubo, J.;
Adachi, M.;
Sotomatsu, M.;
Kikuchi, A.;
Igarashi, T.;
Hayashi, Y.;
Ogawa, S.

Publication type:

Letter

Rapid recovery from panobinostat (LBH589)-induced thrombocytopenia in mice involves a rebound effect of bone marrow megakaryocytes.

Published in:

2011

By:

Giver, C. R.;
Jaye, D. L.;
Waller, E. K.;
Kaufman, J. L.;
Lonial, S.

Publication type:

Letter

Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia.

Published in:

2011

By:

Quintás-Cardama, A.;
Santos, F. P. S.;
Garcia-Manero, G.;
Quintás-Cardama, A

Publication type:

journal article

ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.

Published in:

2011

By:

Thai, M.;
Ting, P. Y.;
McLaughlin, J.;
Cheng, D.;
Müschen, M.;
Witte, O. N.;
Colicelli, J.;
Müschen, M

Publication type:

journal article

Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia.

Published in:

2011

By:

Jabbour, E.;
Deininger, M.;
Hochhaus, A.

Publication type:

Correction Notice

Management of adverse events associated with tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia.

Published in:

2011

By:

Jabbour, E.;
Deininger, M.;
Hochhaus, A.

Publication type:

journal article

NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinases.

Published in:

2011

By:

Reddy, M. M.;
Fernandes, M. S.;
Salgia, R.;
Levine, R. L.;
Griffin, J. D.;
Sattler, M.

Publication type:

journal article

The sequence of application of methotrexate and histone deacetylase inhibitors determines either a synergistic or an antagonistic response in childhood acute lymphoblastic leukemia cells.

Published in:

2011

By:

Bastian, L.;
Einsiedel, H. G.;
Henze, G.;
Seeger, K.;
Shalapour, S.

Publication type:

Letter

JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations.

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 218, doi. 10.1038/leu.2010.269

By:

Pardanani, A.;
Vannucchi, A. M.;
Passamonti, F.;
Cervantes, F.;
Barbui, T.;
Tefferi, A.

Publication type:

Article

Do we have to kill the last CML cell?

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 193, doi. 10.1038/leu.2010.197

By:

Ross, D. M.;
Hughes, T. P.;
Melo, J. V.

Publication type:

Article

The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular response.

Published in:

2011

By:

Jeon, E. K.;
Lim, J.;
Kim, M.;
Yahng, S.-A.;
Lee, S.-E.;
Cho, B.-S.;
Kim, Y.-J.;
Kim, H.-J.;
Min, C.-K.;
Cho, S.-G.;
Kim, D.-W.;
Lee, J.-W.;
Min, W.-S.;
Park, C.-W.;
Lee, S.

Publication type:

Letter

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 348, doi. 10.1038/leu.2010.255

By:

Iqbal, J.;
Weisenburger, D. D.;
Chowdhury, A.;
Tsai, M. Y.;
Srivastava, G.;
Greiner, T. C.;
Kucuk, C.;
Deffenbacher, K.;
Vose, J.;
Smith, L.;
Au, W. Y.;
Nakamura, S.;
Seto, M.;
Delabie, J.;
Berger, F.;
Loong, F.;
Ko, Y.-H.;
Sng, I.;
Liu, X.;
Loughran, T. P.

Publication type:

Article

Synergistic induction of PI-PLCβ1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes.

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 271, doi. 10.1038/leu.2010.266

By:

Follo, M. Y.;
Finelli, C.;
Mongiorgi, S.;
Clissa, C.;
Chiarini, F.;
Ramazzotti, G.;
Paolini, S.;
Martinelli, G.;
Martelli, A. M.;
Cocco, L.

Publication type:

Article

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 254, doi. 10.1038/leu.2010.275

By:

Waanders, E.;
van der Velden, V. H. J.;
van der Schoot, C. E.;
van Leeuwen, F. N.;
van Reijmersdal, S. V.;
de Haas, V.;
Veerman, A. J.;
van Kessel, A. Geurts;
Hoogerbrugge, P. M.;
Kuiper, R. P.;
van Dongen, J. J. M.

Publication type:

Article

Revealing the role of TEL/AML1 for leukemic cell survival by RNAi-mediated silencing.

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 313, doi. 10.1038/leu.2010.277

By:

Zaliova, M.;
Madzo, J.;
Cario, G.;
Trka, J.

Publication type:

Article

Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia.

Published in:

2011

By:

Yu, L.;
Reader, J. C.;
Chen, C.;
Zhao, X. F.;
Ha, J. S.;
Lee, C.;
York, T.;
Gojo, I.;
Baer, M. R.;
Ning, Y.

Publication type:

Letter

A phase-2 trial of low-dose pomalidomide in myelofibrosis.

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 301, doi. 10.1038/leu.2010.254

By:

Begna, K. H.;
Mesa, R. A.;
Pardanani, A.;
Hogan, W. J.;
Litzow, M. R.;
McClure, R. F.;
Tefferi, A.

Publication type:

Article

Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization.

Published in:

2011

By:

Greenbaum, A. M.;
Link, D. C.

Publication type:

journal article

Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia.

Published in:

2011

By:

Otten, J.;
Schmitz, L.;
Vettorazzi, E.;
Schultze, A.;
Marx, A. H.;
Simon, R.;
Krauter, J.;
Loges, S.;
Sauter, G.;
Bokemeyer, C.;
Fiedler, W.

Publication type:

Letter

Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress.

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 236, doi. 10.1038/leu.2010.264

By:

Blalock, W. L.;
Bavelloni, A.;
Piazzi, M.;
Tagliavini, F.;
Faenza, I.;
Martelli, A. M.;
Follo, M. Y.;
Cocco, L.

Publication type:

Article

A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor.

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 259, doi. 10.1038/leu.2010.260

By:

Kako, S.;
Morita, S.;
Sakamaki, H.;
Ogawa, H.;
Fukuda, T.;
Takahashi, S.;
Kanamori, H.;
Onizuka, M.;
Iwato, K.;
Suzuki, R.;
Atsuta, Y.;
Kyo, T.;
Sakura, T.;
Jinnai, I.;
Takeuchi, J.;
Miyazaki, Y.;
Miyawaki, S.;
Ohnishi, K.;
Naoe, T.;
Kanda, Y.

Publication type:

Article

Do we have to kill the last CML cell?

Published in:

2011

By:

Ross, D. M.;
Hughes, T. P.;
Melo, J. V.

Publication type:

Correction Notice

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma.

Published in:

2011

By:

Witzig, T. E.;
Reeder, C. B.;
LaPlant, B. R.;
Gupta, M.;
Johnston, P. B.;
Micallef, I. N.;
Porrata, L. F.;
Ansell, S. M.;
Colgan, J. P.;
Jacobsen, E. D.;
Ghobrial, I. M.;
Habermann, T. M.

Publication type:

journal article

Deletions of Xp22.2 including PIG-A locus lead to paroxysmal nocturnal hemoglobinuria.

Published in:

2011

By:

O'Keefe, C. L.;
Sugimori, C.;
Afable, M.;
Clemente, M.;
Shain, K.;
Araten, D. J.;
List, A.;
Epling-Burnette, P. K.;
Maciejewski, J. P.

Publication type:

Letter

The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia.

Published in:

2011

By:

Chou, W.-C.;
Lei, W.-C.;
Ko, B.-S.;
Hou, H.-A.;
Chen, C.-Y.;
Tang, J.-L.;
Yao, M.;
Tsay, W.;
Wu, S.-J.;
Huang, S.-Y.;
Hsu, S.-C.;
Chen, Y.-C.;
Chang, Y.-C.;
Kuo, K.-T.;
Lee, F.-Y.;
Liu, M.-C.;
Liu, C.-W.;
Tseng, M.-H.;
Huang, C.-F.;
Tien, H.-F.

Publication type:

journal article

Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1.

Published in:

2011

By:

Zhang, L.;
Jiang, Y.;
Zheng, Y.;
Zeng, Y.;
Yang, Z.;
Huang, G.;
Liu, D.;
Gao, M.;
Shen, X.;
Wu, G.;
Yan, X.;
He, F.

Publication type:

journal article

Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping.

Published in:

2011

By:

Costa, E. S.;
Pedreira, C. E.;
Barrena, S.;
Lecrevisse, Q.;
Flores, J.;
Quijano, S.;
Almeida, J.;
del Carmen García-Macias, M.;
Bottcher, S.;
Van Dongen, J. J. M.;
Orfao, A.

Publication type:

Correction Notice

The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 321, doi. 10.1038/leu.2010.253

By:

de Boer, J.;
Yeung, J.;
Ellu, J.;
Ramanujachar, R.;
Bornhauser, B.;
Solarska, O.;
Hubank, M.;
Williams, O.;
Brady, H. J. M.

Publication type:

Article

PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia.

Published in:

2011

By:

Huang, Q.;
Snyder, D. S.;
Chu, P.;
Gaal, K. K.;
Chang, K. L.;
Weiss, L. M.

Publication type:

Letter

Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells.

Published in:

2011

By:

Modi, H.;
Li, L.;
Chu, S.;
Rossi, J.;
Yee, J.-K.;
Bhatia, R.

Publication type:

journal article

Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype.

Published in:

Leukemia (08876924), 2011, v. 25, n. 2, p. 266, doi. 10.1038/leu.2010.258

By:

Patnaik, M. M.;
Hanson, C. A.;
Hodnefield, J. M.;
Knudson, R.;
Van Dyke, D. L.;
Tefferi, A.

Publication type:

Article